Pay in 4 interest-free payments of $43.75 Learn more
Ships within 48 hours · Estimated delivery Aug 6 - Aug 11
Conjugation None Clone# Bevacizumab Formulation 100 mM Pro-Ac 20mM Arg pH 5
and its expression is induced by heat shock
myoepithelial cells in breast and salivary glands
Studies have shown that elevated MMP9 is associated with progression of idiopathic atrial fibrillation and aortic aneurysm
Anti-human TNFRSF10B / TRAILR2 / CD262 (Lexatumumab Biosimilar) Size:1 mg Conjugation None Clone# Bevacizumab FormulationApplication ELISA, Bioactivity: FACS, Functional assay, Research in vivo Reactivity Human, Mouse Target Target Name TNFRSF10B TRAILR2 CD262 Target Uniprot O14763 Overview Catalog# BIO0794SM Product Name Anti human TNFRSF10B TRAILR2 CD262 (Lexatumumab Biosimilar) Specifications Conjugation None Clone# Lexatumumab Formulation 100 mM Pro Ac 20mM Arg pH 5. 0 Storage For long term storage, the produce should be stored at 20 or lower. Reconstitution
US$ 3750.00
US$ 1250.00
US$ 34.99
US$ 14.99
US$ 24.99
US$ 22.95
US$ 26.95
